


noma Therapeutics Email Formats
Biotechnology Research • Boston, Massachusetts, United States • 1-10 Employees
Key Contact at noma Therapeutics
Chrispus Ngule
Co-founder, CEO, President
Company overview
| Headquarters | Boston, Massachusetts, United States |
| Website | |
| NAICS | 541714 |
| Founded | 2025 |
| Employees | 1-10 |
About noma Therapeutics
noma Therapeutics is pioneering small molecule immunotherapies designed to reprogram the tumor microenvironment and restore the immune system’s natural ability to fight cancer. Our platform targets key immunoregulatory pathways that enable tumors to evade immune detection, focusing on reversing immune suppression and enabling more durable anti-tumor responses. Unlike traditional biologics or cell therapies, noma’s small molecules offer a scalable, off-the-shelf approach that penetrates solid tumors and minimizes systemic toxicity. Our candidates aim to synergize with existing immunotherapies, unlocking efficacy in patients who currently fail to respond. noma is built on research from leading academic institutions and supported by a team of scientists from Harvard Medical School with deep experience in immunology, oncology, and translational medicine. The company is based in Boston, MA.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
noma Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
noma Therapeutics has never raised funding before.
Frequently asked questions
4.8
40,000 users



